Clinical trial
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
NCT06863155 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
- Lead sponsor
- Fundación EPIC
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 6, 2025
- Completion date
- March 31, 2029
- Enrollment
- 500 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, ischemic heart disease